FibroBiologics Inc. and Charles River Laboratories, a global provider of drug discovery, development, and manufacturing solutions, have signed a letter of intent allowing for the transfer, testing and validation of FibroBiologics’ technology. This agreement comes ahead of entering into an anticipated master services agreement for the development and manufacture of FibroBiologics’ master cell bank, working cell bank, and fibroblast-based spheroids to be utilized in clinical trials.   FibroBiolo...